Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

• Paloma García-Martín,
• Ana Moñiz Díez,
• José Manuel Sánchez Maldonado,
• Antonio José Cabrera Serrano,
• Rob ter Horst,
• Yolanda Benavente,
• Stefano Landi,
• Angelica Macauda,
• Alyssa Clay-Gilmour,
• Francisca Hernández-Mohedo,
• Yasmeen Niazi,
• Pedro González-Sierra,
• Blanca Espinet,
• Juan José Rodríguez-Sevilla,
• Rossana Maffei,
• Gonzalo Blanco,
• Matteo Giaccherini,
• Anna Puiggros,
• James Cerhan,
• Roberto Marasca,
• Marisa Cañadas-Garre,
• Miguel Ángel López-Nevot,
• Tzu Chen-Liang,
• Hauke Thomsen,
• Irene Gámez,
• Víctor Moreno,
• Rafael Marcos-Gragera,
• María García-Álvarez,
• Javier Llorca,
• Andrés Jerez,
• Sonja Berndt,
• Aleksandra Butrym,
• Aaron D. Norman,
• Delphine Casabonne,
• Mario Luppi,
• Susan L. Slager,
• Kari Hemminki,
• Yang Li,
• Miguel Alcoceba,
• Daniele Campa,
• Federico Canzian,
• Silvia de Sanjosé,
• Asta Försti,
• Mihai G. Netea,
• Manuel Jurado,
• Juan Sainz

Affiliations

Paloma García-Martín

Hospital Campus de la Salud, PTS Granada

Ana Moñiz Díez

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS

José Manuel Sánchez Maldonado

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS

Antonio José Cabrera Serrano

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS

Rob ter Horst

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center

Yolanda Benavente

Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) and University of Barcelona

Stefano Landi

Department of Biology, University of Pisa

Angelica Macauda

Genomic Epidemiology Group, German Cancer Research Center (DKFZ)

Alyssa Clay-Gilmour

Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina

Francisca Hernández-Mohedo

Hematology department, Virgen de las Nieves University Hospital

Yasmeen Niazi

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK)

Pedro González-Sierra

Hematology department, Virgen de las Nieves University Hospital

Blanca Espinet

Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar

Juan José Rodríguez-Sevilla

Hematology Department, Hospital del Mar

Rossana Maffei

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico

Gonzalo Blanco

Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar

Matteo Giaccherini

Department of Biology, University of Pisa

Anna Puiggros

Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar

James Cerhan

Department of Quantitative Health Sciences, Mayo Clinic

Roberto Marasca

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico

Marisa Cañadas-Garre

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS

Miguel Ángel López-Nevot

Immunology Department, Virgen de las Nieves University Hospital

Tzu Chen-Liang

Hematology Department, Morales Meseguer University Hospital

Hauke Thomsen

ProtaGene CGT GmbH

Irene Gámez

Hematology Department, Morales Meseguer University Hospital

Víctor Moreno

CIBER Epidemiología y Salud Pública (CIBERESP)

Rafael Marcos-Gragera

CIBER Epidemiología y Salud Pública (CIBERESP)

María García-Álvarez

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)

Javier Llorca

CIBER Epidemiología y Salud Pública (CIBERESP)

Andrés Jerez

Hematology Department, Morales Meseguer University Hospital

Sonja Berndt

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health

Aleksandra Butrym

Medical University of Wrocław

Aaron D. Norman

Department of Quantitative Health Sciences, Mayo Clinic

Delphine Casabonne

Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) and University of Barcelona

Mario Luppi

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico

Susan L. Slager

Division of Computational Genomics, Mayo Clinic

Kari Hemminki

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)

Yang Li

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center

Miguel Alcoceba

Josep Carreras Leukemia Research Institute

Daniele Campa

Department of Biology, University of Pisa

Federico Canzian

Genomic Epidemiology Group, German Cancer Research Center (DKFZ)

Silvia de Sanjosé

Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) and University of Barcelona

Asta Försti

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK)

Mihai G. Netea

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center

Manuel Jurado

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS

Juan Sainz

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS